Designing an optimized theta-defensin peptide for HIV therapy using in-silico approaches.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Designing an optimized theta-defensin peptide for HIV therapy using in-silico approaches.
- Published In:
- Journal of integrative bioinformatics, 22(1) (2025)
- Database ID:
- RPEP-12646
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12646APA
Mosalanejad, Zahra; Faraji, Seyed Nooreddin; Rahbar, Mohammad Reza; Gholami, Ahmad. (2025). Designing an optimized theta-defensin peptide for HIV therapy using in-silico approaches.. Journal of integrative bioinformatics, 22(1). https://doi.org/10.1515/jib-2023-0053
MLA
Mosalanejad, Zahra, et al. "Designing an optimized theta-defensin peptide for HIV therapy using in-silico approaches.." Journal of integrative bioinformatics, 2025. https://doi.org/10.1515/jib-2023-0053
RethinkPeptides
RethinkPeptides Research Database. "Designing an optimized theta-defensin peptide for HIV therap..." RPEP-12646. Retrieved from https://rethinkpeptides.com/research/mosalanejad-2025-designing-an-optimized-thetadefensin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.